ATAI Life Sciences
ATAI
ATAI
84 hedge funds and large institutions have $109M invested in ATAI Life Sciences in 2021 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
35% less capital invested
Capital invested by funds: $169M → $109M (-$59.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
87% less call options, than puts
Call options by funds: $1.89M | Put options by funds: $14.3M
Holders
84
Holding in Top 10
1
Calls
$1.89M
Puts
$14.3M
Top Buyers
| 1 | +$7.3M | |
| 2 | +$6.02M | |
| 3 | +$3.5M | |
| 4 |
Two Sigma Investments
New York
|
+$3.16M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.1M |
Top Sellers
| 1 | -$9.59M | |
| 2 | -$5.64M | |
| 3 | -$4.7M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.23M |
| 5 |
AWG
Alpha Wave Global
New York
|
-$3.04M |